-
FDA approves self-collection HPV screening test
The FDA approved a human papillomavirus self-collection test that can be gathered in private rooms in primary care offices, urgent care clinics and pharmacies, The Washington Post reported May 15. -
4 cancer vaccine developments
More centers are testing the effectiveness of vaccines on a range of cancers. -
North Carolina hospitals overcharged patients for oncology drugs: Report
North Carolina nonprofit hospitals are under scrutiny for overcharging for oncology drugs they purchased through a federal discount program meant to help disadvantaged patients, Port City Daily reported May 14. -
Cedars-Sinai Cancer taps VP of research
Los Angeles, Calif.-based Cedars-Sinai Cancer named Indrin Chetty, PhD, vice chair of research and director of the medical physics division. -
Supplier acquires 3 Rhode Island radiation cancer centers
American Shared Hospital Services acquired three Rhode Island radiation centers. -
Colorectal cancer rates low, but rising among younger people: Study
New research, which has not been peer-reviewed yet, found colorectal cancer rates have risen between 45% and 500% for people too young for routine screenings, though the overall cancer incidences are still low, NBC News reported May 9. -
Researchers create nanoparticle that crosses blood-brain barrier
Researchers at the Sylvester Comprehensive Cancer Center at the University of Miami have developed a nanoparticle that can cross the blood-brain barrier, potentially opening the door for new treatments for brain metastases. -
8 systems seeking oncology leaders
Here are eight health systems seeking oncology leaders: -
Alabama aims to eliminate cervical cancer in a decade
Health professionals in Alabama aim to eliminate cervical cancer in the state in a decade, The Wall Street Journal reported May 6. -
MD Anderson gets $20M gift to boost neurodegenerative research
The University of Texas MD Anderson Cancer Center in Houston has received a $20 million gift from a longtime donor that will go toward advancing research on Alzheimer's and other types of neurodegenerative diseases. -
FDA targets cancer drugs to be less toxic, more cost effective
The FDA is urging drug companies to pinpoint the cancer drug dosage that has the greatest impact with the fewest side effects. Its most recent study scrutinizes the dosage of a lung cancer drug, The Washington Post reported May 6. -
Valley Children's to offer advanced cancer therapies after $15M gift
An anonymous $15 million donation will enable Valley Children's Healthcare to establish an advanced cellular and gene therapy program, which the Madera, Calif.-based system said will eliminate the need to refer patients to Los Angeles hospitals for certain treatments. -
How oncologists are reducing their burnout
Oncologists are working to reduce their burnout by changing their environment, according to a Medscape report. -
51 cancer centers opening, expanding in 2024
Here are hospitals and health systems opening and expanding cancer centers in 2024: -
Task force lowers breast cancer screening age to 40
Starting at age 40, women should get a mammogram to screen for breast cancer every other year, according to new recommendations from the U.S. Preventive Services Task Force. -
States ranked by cancer death rates
Mississippi had the highest cancer mortality rate in 2019 — over 20% above the national average, a USAFacts report found. -
Breast cancer patients more likely to develop second cancer in lifetime: Study
A study from researchers at University of Cambridge in England found people with breast cancer are more likely to develop a second cancer in their lifetime. -
MD Anderson, Rush bring new partnership to Chicago
Rush MD Anderson Cancer Center is coming to Chicago. The new partnership marks University of Texas MD Anderson's seventh hospital partnership across the U.S., and is expected to expand access to clinical trials and advanced care to patients in Chicago and surrounding communities. -
Hoag taps 2 oncology leaders from Cedars-Sinai
Newport Beach, Calif.-based Hoag Family Cancer Institute recruited an oncologist "power couple" — Monica Mita, MD, and Alain Mita, MD — to serve as leaders in its organization. -
OU Health cancer center expands across state
Oklahoma City-based OU Health Stephenson Cancer Center is expanding to the northeastern part of the state.
Page 1 of 50